Troy– Author –
-
EMA Initiates Review of Otarmeni’s Hereditary Hearing Loss Gene Therapy; Eli Lilly Announces Phase 2 Plans for VERVE-102 in Cardiovascular Disease
LucidQuest Ventures USA Overview Key developments in the cell and gene therapy sector were reported on May 28, 2026, with Otarmeni's hereditary hearing loss gene therapy entering EMA review. Eli Lilly detailed its Phase 2 clinical trial ... -
CRISPR Therapeutics to Detail Broadening Gene-Editing Pipeline at June Investor Conferences, Highlighting Approved Casgevy and Multidisease Programs
Market Chameleon USA Overview CRISPR Therapeutics announced plans to present its expanding gene-editing pipeline at three major investor conferences in early June 2026. The company will discuss the commercial progress of its approved gen... -
Tempus AI and Roswell Park Unveil Groundbreaking AI Algorithms for Pancreatic Cancer and Metastatic RCC at ASCO 2026
Tempus 他 USA Overview At the 2026 ASCO Annual Meeting, Tempus AI and Roswell Park Comprehensive Cancer Center announced significant advancements in AI-driven oncology, showcasing novel algorithms designed to revolutionize cancer diagnos... -
Evolution of Leading Generative AI Foundation Models: Google Gemini 3.5 Flash and Anthropic Claude Opus 4.8 Series Emerge
Amquest Education India Overview As of mid-2026, leading generative AI foundation models include Google DeepMind's Gemini 3.5 Flash and Gemini 3.1 Pro, noted for their native multimodal capabilities and competitiveness against GPT-5 clas... -
OpenAI and Anthropic Dominate AI Revenue, with Anthropic Approaching $30B Annually, as Information Disclosure Asymmetry Becomes Industry Challenge
PR Newswire USA Overview The 2026 AI Company Comms Study by 5WPR reveals that OpenAI and Anthropic are dominating AI revenue, with Anthropic's annualized revenue reaching approximately $30 billion in April 2026, surpassing OpenAI's $25 b... -
AI Accelerates Drug Discovery by Rapidly Screening Candidate Molecules from Large Datasets, Augmenting Scientific Judgment and Reducing Time-to-Market
MedCity News USA Overview AI in drug discovery accelerates processes by efficiently sifting through large datasets of candidate molecules to evaluate properties like potency and selectivity, thereby augmenting scientific judgment and red... -
Google AI Edge Achieves 19.6ms Low-Latency On-Device AI with LiteRT GPU Accelerator on Samsung Galaxy S24
Google AI Edge USA Overview Google AI Edge announced advancements in its LiteRT GPU Accelerator, which, while not yet open-sourced, is available as prebuilts for Kotlin and C++ SDK users. Benchmark results on a Samsung Galaxy S24 device ... -
“Satisfiable Drift” Problem Emerges in Multi-Turn Reasoning of LLMs, Revealed by Novel DRIFT-Bench Benchmark
AI Accelerator Institute International Overview Researchers developed DRIFT-Bench, a solver-instrumented benchmark with 816 test problems across three constraint domains, to evaluate multi-turn reasoning in open-weight models ranging fro... -
Foundation Models Advance Wireless Communications from PHY Intelligence to Network Autonomy via Multimodal Data Alignment and Agentic RAG Frameworks
arXiv International Overview A preprint explores the application of foundation models in wireless communications, from physical layer intelligence to network autonomy. Contrastive foundation models are discussed for aligning multimodal d... -
Meta Aims for AI Differentiation with Enhanced Health Capabilities, Starting with Muse Spark Integration into Consumer Products
Times of India India Overview Alexandr Wang, Meta's Chief AI Officer, announced that future Meta AI models will differentiate themselves through robust health-related capabilities. The Muse Spark model, released in April, has shown promi...
